Abivax (AAVXF) Shares Outstanding (2021 - 2026)

Abivax has reported Shares Outstanding (Entity) for 5 years, with the latest figure at $78.5 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 23.98% year-over-year to $78.5 million in Q4 2025; TTM through Dec 2025 was $78.5 million, a 23.98% increase from a year earlier, with the FY2025 full-year figure at $78.5 million, up 23.98% from the prior year.
• Shares Outstanding (Entity) was $78.5 million for Q4 2025 at Abivax, up from $63.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $78.5 million in Q4 2025, with the low at $16.8 million in Q4 2021.
• Average Shares Outstanding (Entity) over 5 years is $44.8 million, with a median of $43.1 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) surged 93.11% in 2023, then gained 23.98% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $16.8 million in 2021, then soared by 33.1% to $22.3 million in 2022, then surged by 93.11% to $43.1 million in 2023, then jumped by 47.09% to $63.3 million in 2024, then rose by 23.98% to $78.5 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $78.5 million (Q4 2025), $63.3 million (Q4 2024), and $43.1 million (Q4 2023), per Business Quant data.